check_circleStudy Completed

Respiratory Tract Infections

Bayer Identifier:
Trial_0338
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Efficacy and Safety of Ciprofloxacin in the Treatment of Patients with Respiratory Tract Infections

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

16 - 79 Years

Trial summary

Enrollment Goal
39
Trial Dates
January 1984 - December 1984
Phase
N/A
Could I Receive a placebo
N/A
Products
Cipro (Ciprofloxacin hydrochloride, BAYO9867)
Accepts Healthy Volunteer
N/A

Trial design

Efficacy and Safety of BAY O 9867/Ciprofloxacin in the Treatment of Patients with Respiratory Tract Infections (Sequential Therapy Parenteral - Oral)
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.